Nucleosome levels and toll-like receptor expression during high cut-off haemofiltration: a pilot assessment.

[1]  M. Rundgren,et al.  Renal effects of treatment with a TLR4 inhibitor in conscious septic sheep , 2014, Critical Care.

[2]  R. Bellomo,et al.  High Cut-Off Hemofiltration versus Standard Hemofiltration: A Pilot Assessment of Effects on Indices of Apoptosis , 2014, Blood Purification.

[3]  R. Bellomo,et al.  Techniques of extracorporeal cytokine removal: a systematic review of human studies , 2013, Renal failure.

[4]  V. Heinemann,et al.  Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin. , 2013, Cancer letters.

[5]  Douglas Golenbock,et al.  The history of Toll-like receptors — redefining innate immunity , 2013, Nature Reviews Immunology.

[6]  A. Boschetti-de-Fierro,et al.  Extended Characterization of a New Class of Membranes for Blood Purification: The High Cut-off Membranes , 2013, The International journal of artificial organs.

[7]  R. Bellomo,et al.  Techniques of Extracorporeal Cytokine Removal: A Systematic Review of the Literature on Animal Experimental Studies , 2013, The International journal of artificial organs.

[8]  C. Esmon,et al.  Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C , 2012, Critical care medicine.

[9]  Yue Jin,et al.  Circulating nucleosomes as a predictor of sepsis and organ dysfunction in critically ill patients. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[10]  R. Bellomo,et al.  Techniques of Extracorporeal Cytokine Removal: A Systematic Review of the Literature , 2012, Blood Purification.

[11]  S. Su,et al.  The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases. , 2011, International immunopharmacology.

[12]  M. Rundgren,et al.  Toll-like receptor 4 inhibitor TAK-242 attenuates acute kidney injury in endotoxemic sheep. , 2011, Anesthesiology.

[13]  J. Kellum,et al.  Clinical review: Blood purification for sepsis , 2011, Critical care.

[14]  Xiaoyuan Chen,et al.  Apoptosis Imaging: Beyond Annexin V , 2010, The Journal of Nuclear Medicine.

[15]  E. Abraham,et al.  Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine? , 2010, Intensive Care Medicine.

[16]  P. Bruneval,et al.  Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration , 2010, Intensive Care Medicine.

[17]  Shizuo Akira,et al.  The roles of TLRs, RLRs and NLRs in pathogen recognition. , 2009, International immunology.

[18]  S. Lewin,et al.  Regulation of Toll‐like receptor‐2 expression in chronic hepatitis B by the precore protein , 2007, Hepatology.

[19]  E. Baldissera,et al.  Accumulation of plasma nucleosomes upon treatment with anti‐tumour necrosis factor‐α antibodies , 2004 .

[20]  B. Lämmle,et al.  Elevated nucleosome levels in systemic inflammation and sepsis* , 2003, Critical care medicine.

[21]  R. Bellomo,et al.  Blood Purification in Non-Renal Critical Illness , 2003, Blood Purification.

[22]  Ruslan Medzhitov,et al.  Toll-like receptors and innate immunity , 2001, Nature Reviews Immunology.

[23]  R. Hotchkiss,et al.  Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. , 1999, Critical care medicine.

[24]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[25]  C. Bortner,et al.  The role of DNA fragmentation in apoptosis. , 1995, Trends in cell biology.